Neurology:AD与路易士小体性痴呆的认知功能会受APOE ɛ4影响吗?

2020-06-10 shaosai MedSci原创

本研究旨在验证是否APOE ε4会影响Alzheimer病(AD)和路易士小体性痴呆(DLB)在白质异常高信号(WMH)与认知损伤间的相关性。

目的

本研究旨在验证是否APOE ε4会影响Alzheimer病(AD)和路易士小体性痴呆(DLB)在白质异常高信号(WMH)与认知损伤间的相关性。

方法

本研究共纳入了289 例患者,并行容积MRI、神经心理学测试和APOE ε4亚型分析。计算总的WMH体积。神经心理学测试量表评分作为分析认知功能(包括注意力、高级执行功能、学习/记忆及语言)的指标,计算每个患者每个功能的评分。在所有样本中测试WMH与APOE ε4交互作用后,利用线性回归模型评价APOE ε4 (n = 167)阳性和APOE ε4 阴性(n = 122)患者WMH与指标评分的相关性。我们对APOE ε4携带者的WMH体积与认知功能损害间的相关性更强烈。然后对198例AD患者(ADNI-I)进行重复性结果验证,对两个样本的评价进行META分析。

结果

关于语言,WMH体积与APOE ε4间具有显著的交互作用,而在记忆或高级功能间并没有交互作用。在APOE ε4携带者和费携带间单独分析中显示在APOE ε4携带者WMH体积越大与注意力/高级功能、学习/记忆和语言越差中具有相关性。在ADNI-I中,WMH负荷越高于APOE ε4携带者的注意力/高级功能、语言越差具有相关性。Meta分析显示仅在APOE ε4携带者中WMH体积越大与所有认知功能下降具有相关性。

结论

在AD和DLB患者中APOE ε4会影响WMH与认知功能的相关性。

原始出处

:Mirza SS, Saeed U, Knight J.et al. APOE ɛ4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia.DOI: 10.1212/WNL.0000000000008377

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2001058, encodeId=f4662001058fd, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 29 14:09:53 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888648, encodeId=5f728886485b, content=不止这个因素会影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/5278ce3e7bbaac83661038bc2facdf85.jpg, createdBy=cf2a5328500, createdName=王志英, createdTime=Sun Sep 27 08:49:04 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590605, encodeId=22001590605ad, content=<a href='/topic/show?id=c80a2666f2' target=_blank style='color:#2F92EE;'>#APOE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2666, encryptionId=c80a2666f2, topicName=APOE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9817837767, createdName=xiongke016, createdTime=Fri Jun 12 12:09:53 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602018, encodeId=7af660201866, content=还有其他因素, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Jun 11 09:42:03 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048627, encodeId=9aae104862e0c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 11 00:09:53 CST 2020, time=2020-06-11, status=1, ipAttribution=)]
    2020-12-29 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2001058, encodeId=f4662001058fd, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 29 14:09:53 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888648, encodeId=5f728886485b, content=不止这个因素会影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/5278ce3e7bbaac83661038bc2facdf85.jpg, createdBy=cf2a5328500, createdName=王志英, createdTime=Sun Sep 27 08:49:04 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590605, encodeId=22001590605ad, content=<a href='/topic/show?id=c80a2666f2' target=_blank style='color:#2F92EE;'>#APOE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2666, encryptionId=c80a2666f2, topicName=APOE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9817837767, createdName=xiongke016, createdTime=Fri Jun 12 12:09:53 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602018, encodeId=7af660201866, content=还有其他因素, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Jun 11 09:42:03 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048627, encodeId=9aae104862e0c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 11 00:09:53 CST 2020, time=2020-06-11, status=1, ipAttribution=)]
    2020-09-27 王志英

    不止这个因素会影响

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2001058, encodeId=f4662001058fd, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 29 14:09:53 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888648, encodeId=5f728886485b, content=不止这个因素会影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/5278ce3e7bbaac83661038bc2facdf85.jpg, createdBy=cf2a5328500, createdName=王志英, createdTime=Sun Sep 27 08:49:04 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590605, encodeId=22001590605ad, content=<a href='/topic/show?id=c80a2666f2' target=_blank style='color:#2F92EE;'>#APOE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2666, encryptionId=c80a2666f2, topicName=APOE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9817837767, createdName=xiongke016, createdTime=Fri Jun 12 12:09:53 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602018, encodeId=7af660201866, content=还有其他因素, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Jun 11 09:42:03 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048627, encodeId=9aae104862e0c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 11 00:09:53 CST 2020, time=2020-06-11, status=1, ipAttribution=)]
    2020-06-12 xiongke016
  4. [GetPortalCommentsPageByObjectIdResponse(id=2001058, encodeId=f4662001058fd, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 29 14:09:53 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888648, encodeId=5f728886485b, content=不止这个因素会影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/5278ce3e7bbaac83661038bc2facdf85.jpg, createdBy=cf2a5328500, createdName=王志英, createdTime=Sun Sep 27 08:49:04 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590605, encodeId=22001590605ad, content=<a href='/topic/show?id=c80a2666f2' target=_blank style='color:#2F92EE;'>#APOE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2666, encryptionId=c80a2666f2, topicName=APOE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9817837767, createdName=xiongke016, createdTime=Fri Jun 12 12:09:53 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602018, encodeId=7af660201866, content=还有其他因素, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Jun 11 09:42:03 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048627, encodeId=9aae104862e0c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 11 00:09:53 CST 2020, time=2020-06-11, status=1, ipAttribution=)]
    2020-06-11 神盾医疗局局长Jack

    还有其他因素

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2001058, encodeId=f4662001058fd, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Dec 29 14:09:53 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888648, encodeId=5f728886485b, content=不止这个因素会影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/13/5278ce3e7bbaac83661038bc2facdf85.jpg, createdBy=cf2a5328500, createdName=王志英, createdTime=Sun Sep 27 08:49:04 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1590605, encodeId=22001590605ad, content=<a href='/topic/show?id=c80a2666f2' target=_blank style='color:#2F92EE;'>#APOE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2666, encryptionId=c80a2666f2, topicName=APOE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9817837767, createdName=xiongke016, createdTime=Fri Jun 12 12:09:53 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602018, encodeId=7af660201866, content=还有其他因素, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Jun 11 09:42:03 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048627, encodeId=9aae104862e0c, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Thu Jun 11 00:09:53 CST 2020, time=2020-06-11, status=1, ipAttribution=)]
    2020-06-11 junJUN

    老年人痴呆何药可用??

    0

相关资讯

JAMA Neurol:KL-VSHET+基因型与较低的阿尔茨海默病风险

基因型KL-VSHET+携带者的阿尔茨海默病风险较低,与其相关信号通路研究有望成为治疗AD的新靶点

JAMA Neurol:[18F]flortaucipir PET在AD神经病理学改变检测中的应用

[18F]flortaucipir PET显像可用于鉴别AD型tau病理的密度和分布,以及高水平的AD神经病理学改变,支持AD的神经病理学诊断

JAMA Neurol:tau-PET示踪剂RO948 F18对阿尔茨海默病具有极高的鉴别能力

tau-PET示踪剂RO948 F18对AD型tau病变具有极高的特异性,在AD的鉴别诊断中具有潜在的诊断价值。

JAMA Neurol:Lanabecestat治疗早期AD研究失败

lanabecestat无法减缓早期AD患者认知或功能下降

JAMA Neurol:APOE4、Aβ以及tau蛋白的相关性研究

研究表明,APOE4阳性痴呆的发病机制涉及淀粉样蛋白-β和tau蛋白聚集2种机制